Safety and clinical activity of atezolizumab in combination with tazemetostat in relapsed or refractory diffuse large B-cell lymphoma: Primary analysis of a phase 1B study Meeting Abstract
| Authors: | Palomba, M. L.; Cartron, G.; Popplewell, L.; Ribrag, V.; Westin, J.; Chitra, S.; Huw, L.; Newberry, K.; Raval, A.; Xu, J.; Morschhauser, F. |
| Abstract Title: | Safety and clinical activity of atezolizumab in combination with tazemetostat in relapsed or refractory diffuse large B-cell lymphoma: Primary analysis of a phase 1B study |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 517 |
| End Page: | 519 |
| Language: | English |
| ACCESSION: | 137029249 |
| DOI: | 10.1002/hon.203_2631 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 493 -- Source: cin20 |
